Publicacións nas que colabora con ANTONIO AGUILERA GUIRAO (25)

2022

  1. Biotecnología para el diagnóstico, tratamiento y prevención de las enfermedades infecciosas en acuicultura

    SEM@foro, Núm. 74, pp. 53-54

2020

  1. Molecular and serological typing of Streptococcus mutans strains isolated from young Galician population: relationship with the oral health status

    International microbiology: official journal of the Spanish Society for Microbiology, Vol. 23, Núm. 4, pp. 589-596

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2011

  1. Variabilidad en la determinación del tropismo viral del VIH utilizando diferentes algoritmos genotípicos de interpretación en pacientes VIH-1 infectados con subtipos B versus no-B

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 1, pp. 4-8

2010

  1. Automated extraction improves multiplex molecular detection of infection in septic patients

    PLoS ONE, Vol. 5, Núm. 10

2008

  1. Implication of p38 mitogen-activated protein kinase isoforms (α, β, γ and δ) in CD4+ T-cell infection with human immunodeficiency virus type 1

    Journal of General Virology, Vol. 89, Núm. 7, pp. 1661-1671

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica

2006

  1. Detección de ADN de CMV en plasma mediante PCR en tiempo real utilizando SYBR-Green I como señal de amplificación

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 9, pp. 541-545

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. Construction and characterization of a minimized version of the HIV-1 pNL4-3 plasmid and its application for pseudotyping HIV-1 vectors

    Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology, Vol. 28, Núm. 2, pp. 87-95

  2. Total HCV core antigen assay: A new marker of HCV viremia and its application during treatment of chronic hepatitis C

    Journal of Virological Methods, Vol. 120, Núm. 2, pp. 173-177

2003

  1. Virus GB-C: ausencia de asociación con niveles de transaminasas, CD4 y carga vírica en pacientes con sida

    Anales de medicina interna, Vol. 20, Núm. 4, pp. 175-178

2002

  1. Infection with retroviruses other than HIV-1 in Spain: A retrospective analysis for HIV-2, HTLV-I, and/or HTLV-II

    HIV Clinical Trials, Vol. 3, Núm. 5, pp. 397-402

2001

  1. Diarrea por adenovirus y astrovirus en pacientes inmunodeficientes hospitalizados

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 19, Núm. 1, pp. 7-10

2000

  1. Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples [6]

    Journal of Clinical Microbiology

  2. Prevalence of HTLV infection in pregnant women in Spain

    Sexually Transmitted Infections, Vol. 76, Núm. 5, pp. 366-370

1999

  1. Intestinal myiasis caused by Eristalis tenax [4]

    Journal of Clinical Microbiology

1998

  1. Clostridium difficile bacteremia in an immunocompetent child [3]

    Journal of Clinical Microbiology

1997

  1. False-negative result in a microparticle enzyme immunoassay (MEIA) for the detection of antibodies to human immunodeficiency (HIV) [1]

    Scandinavian Journal of Infectious Diseases